Clinical usefulness of genetic testing for drug toxicity in cancer care : decision-makers’ framing, knowledge and perceptions
To explore the clinical uptake of pharmacogenetic/pharmacogenomic toxicity testing to reduce adverse drug reaction incidences, this paper analyzes data collected through semi-structured face-to-face interviews with clinicians and/or clinician-scientists, primarily in the context of cancer treatment...
Saved in:
Main Author: | Sun, Shirley |
---|---|
Other Authors: | School of Social Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/145485 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
International Clinical Sociology
by: Jan Marie Fritz.
Published: (2017) -
Regulation of glucose and glutamine uptake and the production of monoclonal antibody in hybridoma cultures
by: Lee, Y.-K., et al.
Published: (2014) -
General practitioners' (GPs) experience, attitudes and needs on clinical genetic services: a systematic review
by: Ong, Cheryl Siow Bin, et al.
Published: (2023) -
Clinical value of add-on chemistry testing in a large tertiary-care teaching hospital
by: Loh, T.P., et al.
Published: (2016) -
Action of carriers on drug dissolution
by: Wan, L.S.C., et al.
Published: (2014)